Surviving patients	Deceased patients	p
No. of patients	59	8
SAPS-II at admission	38.3 (95% CI:	47.4 (95% CI:	0.038
	35.05–41.58)	39.15–55.60)
Presence of septic shock	5 (8.5%)	3 (37.5%)	0.048
Multiresistant microorganisms isolated	20 (33.9%)	3 (37.5%)	1.00
Type of multiresistant microorganisms		0.652
EBSLa-producing	9 (45%)	1 (33.3%)
Pseudomonas aeruginosab	2 (10%)	0
Other multiresistant Gram(−)b	7 (35%)	1 (33.3%)
Gram(+) microorganismsc	2 (10%)	1 (33.3%)
Polymicrobial infections	12 (20.3%)	3 (37.5%)
Evaluation of mortality	Odds ratio	95%CI	p
SAPS-II at admission	1.060	0.997–1.127	0.061
Presence of septic shock	6.480	1.184–35.452	0.031
Multiresistant microorganisms	1.170	0.253–5.401	0.841

^aEBSL, extended-spectrum β-lactamase.

^bResistant to more than 3 antibiotic families.

^cPresence of methicillin or vancomycin resistance.